glp 1 patents Patent and Innovation Trends in GLP-1 and Weight Loss Drugs (2020–2025) US12291530B1 - GLP-1R agonist and

Possible role for metallothionein in protection against radiation-induced oxidative stress

Image Credit: Gecko Studio / Shutterstock In a recent review published in The Lancet , researchers synthesized decades of research on incretin-based medications

Importantly, the researchers also showed that the compound was active against all three major species of Schistosoma worms that infect humans

Low glutathione levels lead to an impaired immune system, decreased ability to detoxify, and impaired ability to fight free radicals, which combine to exacerbate the symptoms of aging, such as fatigue, slow recovery from activities, prolonged illnesses, and more